---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-24-000036"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T01:08:21.667182+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q3 non-GAAP EPS $2.08 (+20% YoY); raises FY24 EPS guidance to $7.30-$7.40

## Summary
- Revenue $54.9B (+9% YoY); GAAP diluted EPS $1.05; non-GAAP diluted EPS $2.08 (+20%).
- Pharma & Specialty Solutions segment profit $580M (+4%); Global Medical Products segment profit $20M vs -$46M a year ago.
- FY2024 non-GAAP EPS guidance raised to $7.30-$7.40 (from $7.20-$7.35); non-GAAP effective tax rate guidance lowered to 22%-23%.
- Preliminary FY2025 non-GAAP EPS guidance at least $7.50; Pharma segment profit growth at least 1%; GMPD segment profit ~$175M.

## SEC filing metadata
- accession: 0000721371-24-000036
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137124000036/0000721371-24-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000036/cah-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-24-000036
- JSON: https://secwatch.observer/filing/0000721371-24-000036.json
- Plain text: https://secwatch.observer/filing/0000721371-24-000036.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported third quarter fiscal year 2024 results: revenue $54.9 billion, net income $258 million, EPS $1.05. Guidance raised.
  - Period: third quarter fiscal year 2024
  - Revenue: $54.9 billion
  - Net income: $258 million
  - EPS: $1.05
  - Guidance: raised
  - Result: reported results
  source text: Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance • Revenue increased 9% to $54.9 billion • GAAP 1 operating earnings were $367 million; GAAP diluted EPS was $1.05 • Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased 20% to $2.08 • Fiscal year 2024 non-GAAP EPS guidance 2 raised and narrowed to $7.30 to $7.40, from $7.20 to $7.35 • Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137124000036/0000721371-24-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.